Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2020 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
13-05-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
13-05-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Themis Medicare Ltd has submitted to BSE a Clarification as follows:"All the material information, that have a bearing on the operations/performance of the Company which include all price sensitive information under Regulation 30 of SEBI [Listing Obligations and Disclosure Requirements) Regulations, 2015 ["Listing Regulations"), have always been disclosed by the Company within the stipulated time. Further, the Company has always provided timely clarification / information sought by the Stock Exchanges. There is no pending information or announcement from the Company which may have a bearing on the price movement of the Company. The current movement in the share price of the Company is based purely due to market conditions and absolutely market driven and the Company is in no way connected with any such movement in price."
17-04-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Clarification sought from Themis Medicare Ltd

The Exchange has sought clarification from Themis Medicare Ltd on April 17th, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
17-04-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (PIT) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2-04-19 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1-04-20 and will re-open after completion of 48 hours from the declaration of financial results for the quarter and year ended 31-03-20 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter and year ended 31-03-20 shall be intimated in due course. This is for your information and record.
31-03-2020
Bigul

Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement published in newspaper(s) viz. the 'Indian Express' (English) and 'Financial Express' (Gujarati) newspaper dated 8th February, 2020 for the Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31, 2019. Kindly take the same on record
12-02-2020
Bigul

Themis Medicare Ltd - 530199 - Results -Financial Results For The Quarter And Nine Months Ended 31St December, 2019

The Board of Directors at its meeting held today, considered and approved the following matters: 1.Approved the Unaudited Standalone and Consolidated financial results for the Quarter and Nine Months ended 31st December, 2019. 2.Alloted 7050 Equity Shares to eligible employees'' pursuant to exercise of ESOP Options under Themis ESOS Scheme 2012. 3.Approved proposal to seek consent of members under Section 188 of the Companies Act, 2013 for proposed Related Party Transaction. 4.Approved Draft Notice of Postal Ballot for seeking consent of members under Section 188 of the Companies Act, 2013 for proposed Related Party Transaction 5.Appointed M/s. Shirish Shetye and Associates as scrutinizer for the purpose of conducting postal ballot. 6.Appointed M/s. Shirish Shetye and Associates as Secretarial Auditor for the financial year 2019-20 for the purpose of conducting Secretarial Audit. This may be taken as compliance under the Listing Regulations.
07-02-2020
Bigul

Themis Medicare Ltd - 530199 - Outcome Of Board Meeting Held On February 07, 2020

1.Approved the Unaudited Standalone and Consolidated financial results for the Quarter and Nine Months ended 31st December, 2019. 2.Alloted 7050 Equity Shares to eligible employees' pursuant to exercise of ESOP Options under Themis ESOS Scheme 2012. 3.Approved proposal to seek consent of members under Section 188 of the Companies Act, 2013 for proposed Related Party Transaction. 4.Approved Draft Notice of Postal Ballot for seeking consent of members under Section 188 of the Companies Act, 2013 for proposed Related Party Transaction 5.Appointed M/s. Shirish Shetye and Associates as scrutinizer for the purpose of conducting postal ballot. 6.Appointed M/s. Shirish Shetye and Associates as Secretarial Auditor for the financial year 2019-20 for the purpose of conducting Secretarial Audit. This may be taken as compliance under the Listing Regulations.
07-02-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the copy of newspaper advertisement of Notice of the Meeting of the Board of Directors of Themis Medicare Limited scheduled to be held on Friday,February 07, 2020, published in The Times of India - (English Newspaper) and The Economic Times - Ahmedabad Gujarat (Gujarati Newspaper) on 29th January, 2020 for your reference.
31-01-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for For The Un-Audited Standalone And Consolidated Financial Results For The Quarter/ Nine Months Ended On 31St December, 2019

THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter/ Nine months ended on 31st December, 2019.
27-01-2020
Next Page
Close

Let's Open Free Demat Account